According to Tilray 's latest financial reports the company's current earnings (TTM) are -$0.32 B. a decrease over its 2022 earnings that were of -$0.55 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$1.42 B | 160.9% |
2022 | -$0.55 B | |
2020 | -$0.15 B | 169.31% |
2019 | -$54.86 M | -196.89% |
2018 | $56.6 M | 227.38% |
2017 | $17.29 M | 1488.68% |
2016 | $1.08 M | -138.43% |
2015 | -$2.84 M | 2427.52% |
2014 | -$0.12 M | 329.55% |
2013 | -$0.03 M | -77.3% |
2012 | -$0.12 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -41.98% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -94.04% | ๐บ๐ธ USA |